Want to create an interactive transcript for this episode?
Podcast: GSD Venture Studios Podcasts by Gary Fowler
Episode: Scaling Human Bioequivalence: The New Frontier of Organoids and AI with Daniel Delubac
Description: Join Daniel Delubac, CEO of IORGANBIO, for a deep dive into the breakthrough technologies reshaping modern medicine. From non-invasive prenatal testing to the first AI-agentic platforms for synthetic chemistry, Daniel has been at the center of the world's most significant biotech innovations. In this episode, we explore how IORGANBIO is merging first-principles engineering with AI to manufacture human bioequivalent cells and organoids at scale—replacing outdated animal models and paving the way for accessible, $n$-of-one regenerative medicine.🎯 Insights You’ll Learn:✓ The Power of NAMs: Why organoids are the key to moving pa...